Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage
Abstract
The principal regulator of p53 stability is HDM2, an E3 ligase mediating p53 degradation via the ubiquitin-26S proteasome pathway. Until recently, the accepted model held that p53 degradation occurs exclusively on cytoplasmic proteasomes, with an absolute requirement for nuclear export of p53 via the CRM1 pathway. However, 26S proteasomes are abundant in cytosol and nucleus. Using forced overexpression of HDM2 in mutant p53 tumor cells, we previously found that p53 degradation occurs in both the nucleus and the cytoplasm. p53 null cells coexpressing export-defective p53 and HDM2 retained partial competence for p53 degradation, challenging the obligatory export model. Because the ability of local nuclear destruction might add important control in switching off the p53 pathway, we now test this notion for physiological situations in untransfected cells and determine the significance of this regulation. Despite nuclear export blockade by leptomycin B and HTLV1-Rex protein, two potent CRM1 inhibitors, nuclear degradation of endogenous wild-type p53 and HDM2 occurs during down-regulation of the p53 response. This was seen in RKO and U2OS cells recovering from all major forms of DNA damage, including UV, gamma-IR, camptothecin, or cisplatinum. Moreover, significant nuclear degradation of endogenous p53 and HDM2 occurs in isolated nuclear fractions prepared from these recovering cells. Furthermore, nuclear proteasomes efficiently degrade ubiquitinated p53 in vitro. Our data indicate that in nonlethal outcomes of cellular stress, when DNA damage has been successfully repaired and the active p53 response needs to be down-regulated quickly to resume normal homeostasis, both nuclear and cytoplasmic proteasomes are recruited to efficiently degrade the elevated p53 and HDM2 protein levels. The physiological significance of local nuclear destruction lies in the fact that it adds tighter control and speed to switching the p53 pathway off.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Proteasome-dependent degradation of nuclear p53 can also effectively prevent its transactivation function, suggesting that monoubiquitylation of cytoplasmic p53 is required for other processes.
“However, proteasome-dependent degradation of nuclear p53 can also effectively prevent its transactivation function [111,112], suggesting monoubiquitylation of cytoplasmic p53 is required for other processes.”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [112]
Cites
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · see citing works
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · see citing works
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951 · see citing works
Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044 · see citing works
Stommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., & Wahl, G. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1660 · Cited by 738 · see citing works
Self-citationIn vivo ubiquitination and proteasome-mediated degradation of p53(1).
Maki, C. G., Huibregtse, J. M., & Howley, P. M. (1996) · PubMed · Cited by 645 · see citing works
Roth, J., Dobbelstein, M., Freedman, D. A., Shenk, T., & Levine, A. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.554 · Cited by 610 · see citing works
Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6
Freedman, D. A., & Levine, A. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7288 · Cited by 513 · see citing works
Henderson, B. R., & Eleftheriou, A. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4825 · Cited by 394 · see citing works
A p53 Amino-Terminal Nuclear Export Signal Inhibited by DNA Damage-Induced Phosphorylation
Zhang, Y., & Xiong, Y. (2001) · Science · doi:10.1126/science.1058637 · Cited by 378 · cited 2× · see citing works
“The amino-terminal NES is blocked by DNA damage-induced phosphorylation, suggesting it operates only in unstressed cells ( 11 ).”
BackgroundThe MDM2 RING-finger domain is required to promote p53 nuclear export
Geyer, R. K., Yu, Z. K., & Maki, C. G. (2000) · Nature Cell Biology · doi:10.1038/35023507 · Cited by 361 · see citing works
Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53
Tao, W., & Levine, A. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3077 · Cited by 355 · see citing works
An intact HDM2 RING-finger domain is required for nuclear exclusion of p53
Boyd, S. D., Tsai, K. Y., & Jacks, T. (2000) · Nature Cell Biology · doi:10.1038/35023500 · Cited by 334 · see citing works
Subcellular localization of proteasomes and their regulatory complexes in mammalian cells
BROOKS, P., Fuertes, G., Murray, R. Z., Bose, S., Knecht, E., Rechsteiner, M., Hendil, K. B., Tanaka, K., Dyson, J., & Rivett, A. J. (2000) · Biochemical Journal · doi:10.1042/bj3460155 · Cited by 304 · see citing works
Dynamics of proteasome distribution in living cells
Reits, E. A., Benham, A. M., Plougastel-Douglas, B., Neefjes, J., & Trowsdale, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.20.6087 · Cited by 271 · see citing works
C-Terminal Ubiquitination of p53 Contributes to Nuclear Export
Lohrum, M. A. E., Woods, D. B., Ludwig, R. L., Bálint, É., & Vousden, K. H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8521-8532.2001 · Cited by 237 · see citing works
Mdm2 association with p53 targets its ubiquitination
Fuchs, S. Y., Adler, V., Buschmann, T., Wu, X., & Ronai, Z. A. (1998) · Oncogene · doi:10.1038/sj.onc.1202200 · Cited by 235 · see citing works
Kumar, K. P., McBride, K. M., Weaver, B. K., Dingwall, C., & Reich, N. C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4159-4168.2000 · Cited by 209 · see citing works
Subpopulations of proteasomes in rat liver nuclei, microsomes and cytosol
Palmer, A., Rivett, A. J., Thomson, S., Hendil, K. B., Butcher, G. W., Fuertes, G., & Knecht, E. (1996) · Biochemical Journal · doi:10.1042/bj3160401 · Cited by 171 · see citing works
Lai, Z., Ferry, K. V., Diamond, M. A., Wee, K. E., Kim, Y. B., Ma, J., Yang, T., Benfield, P. A., Copeland, R. A., & Auger, K. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011517200 · Cited by 168 · see citing works
Laı́n, S., Midgley, C., Sparks, A., Lane, E. B., & Lane, D. P. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4433 · Cited by 135 · see citing works
MDM2-dependent ubiquitination of nuclear and cytoplasmic P53
Yu, Z. K., Geyer, R. K., & Maki, C. G. (2000) · Oncogene · doi:10.1038/sj.onc.1203980 · Cited by 133 · see citing works
Cocompartmentalization of p53 and Mdm2 Is a Major Determinant for Mdm2-Mediated Degradation of p53
Xirodimas, D. P., Stephen, C. W., & Lane, D. P. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5314 · Cited by 127 · see citing works
Intracellular targeting of the proteasome
Hirsch, C., & Ploegh, H. L. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01768-2 · Cited by 107 · see citing works
Changes in proteasome localization during the cell cycle.
Palmer, A., MASON, G. G. F., Paramio, J. M., et al. (1994) · PubMed · Cited by 104 · see citing works
Nuclear degradation of p53 occurs during down‐regulation of the p53 response after DNA damage
Shirangi, T. R., Zaika, A., & Moll, U. M. (2002) · The FASEB Journal · doi:10.1096/fj.01-0617fje · Cited by 96 · see citing works
Self-citationSmart, P., Lane, E. B., Lane, D. P., Midgley, C., Vojtesek, B., & Laı́n, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203260 · Cited by 73 · see citing works
Katahira, J., Ishizaki, T., Sakai, H., Adachi, A., Yamamoto, K., & Shida, H. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.3125-3133.1995 · Cited by 67 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The p53 orchestra: Mdm2 and Mdmx set the tone
Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450 · see citing works
Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding
Marchenko, N. D., Hanel, W., Li, D., Becker, K., Reich, N., & Moll, U. M. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.173 · Cited by 123 · see citing works
Self-citation
- Authors
- Joseph, T. W., Zaika, A., & Moll, U. M.
- Affiliations
- State University of New York (US)
- ORCID
- Moll, Ute M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2003-09
- Volume
- 17
- Issue
- 12
- Pages
- 1622-1630
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2048410022
- Cited by
- 50
- References
- 28
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2020: 3 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 2 · 2013: 2
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (T32CA009176, T32 CA09176-24)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53 degradation, MDM2, nuclear proteasome, CRM1 nuclear export, DNA damage response, leptomycin B, UV damage, gamma irradiation, camptothecin, cisplatin, DNA repair, tumor suppressor regulation
- MeSH terms
- Cell Nucleus, Cysteine Endopeptidases, Cytoplasm, DNA Damage, Humans, Multienzyme Complexes, Nuclear Proteins, Proto-Oncogene Proteins, Tumor Cells, Cultured, Ubiquitins, Down-Regulation, Tumor Suppressor Protein p53, Proteasome Endopeptidase Complex, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review